Product Information
GLIPIZIDE ER 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1217 per EA under NDC 64980028101. Its NADAC has been published 478 times since Aug 9, 2017.
FDA first approved this application on Dec 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980028101
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204720FDA Approved
12/29/2016
TE Code
AB
On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE ER 10 MG TABLET has been published 478 times since Aug 9, 2017, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1217 per EA |
|---|---|
| All-time high | $0.2740 (Mar 14, 2018) |
| All-time low | $0.1217 (Sep 23, 2026) |
| 52-week high | $0.1422 |
| 52-week low | $0.1217 |
| Median price | $0.1832 |
| Average price | $0.1891 |
| Largest weekly change | -20.0% (Apr 17, 2024) |
| Weeks tracked | 478 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glipizide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIPIZIDE ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE ER 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1217 per EA (NDC 64980028101), effective Sep 30, 2026.
How has the price of GLIPIZIDE ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE ER 10 MG TABLET has declined 53.5%. It has been tracked across 478 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE ER 10 MG TABLET?
Since Aug 9, 2017, the NADAC for GLIPIZIDE ER 10 MG TABLET has ranged from a low of $0.1217 (Sep 23, 2026) to a high of $0.2740 (Mar 14, 2018), with a median of $0.1832 per EA.
Are there cheaper alternatives to GLIPIZIDE ER 10 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIPIZIDE 10 MG TABLET, is $0.0448 per EA — about 63% below GLIPIZIDE ER 10 MG TABLET.
Who manufactures GLIPIZIDE ER 10 MG TABLET?
GLIPIZIDE ER 10 MG TABLET (NDC 64980028101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.